(CGNX) Cognex - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1924221039

CGNX: Machine Vision, Software, Sensors, Barcode Readers

Cognex Corporation (NASDAQ:CGNX) is a leader in machine vision technology, empowering industries to automate and optimize manufacturing and logistics processes. By capturing and analyzing visual data, their systems enable precise automation in tasks like inspecting, identifying, and tracking products. This is critical in high-precision industries such as consumer electronics, automotive, and pharmaceuticals, where even minor defects can have significant consequences.

Their product lineup is extensive, featuring VisionPro software, which offers advanced tools for complex vision applications, and QuickBuild, a user-friendly platform for building vision applications through a graphical interface. They also leverage deep learning in their vision software, enhancing accuracy and adaptability in challenging inspection tasks. Additionally, they provide a range of vision sensors and the In-Sight product line, which combines vision systems and sensors for versatile applications. Their DataMan series of image-based barcode readers and verifiers ensures accurate identification and verification in fast-paced environments.

Cognex serves a diverse array of sectors, including logistics, consumer electronics, medical devices, semiconductors, and food and beverage. Their solutions are integral to manufacturing workflows, assisting in part location, measurement, assembly verification, and robotic guidance. This versatility underscores the broad applicability of their technology across various industries.

Founded in 1981 and headquartered in Natick, Massachusetts, Cognex has established itself as a trusted name in machine vision. Their distribution network includes a global array of distributors and integrators, facilitating widespread adoption of their solutions. Investors and fund managers may note that Cognex operates with a market cap of approximately $5.76 billion, a P/E ratio of 54.43, and a forward P/E of 28.90, alongside a P/B ratio of 3.80 and a P/S ratio of 6.30. These metrics highlight the companys valuation in the current market landscape.

Additional Sources for CGNX Stock

CGNX Stock Overview

Market Cap in USD 5,081m
Sector Technology
Industry Scientific & Technical Instruments
GiC Sub-Industry Electronic Equipment & Instruments
IPO / Inception 1989-07-20

CGNX Stock Ratings

Growth 5y -49.5%
Fundamental -7.43%
Dividend 24.3%
Rel. Strength -27.7
Analysts 3.86/5
Fair Price Momentum 24.56 USD
Fair Price DCF 12.32 USD

CGNX Dividends

Dividend Yield 12m 0.90%
Yield on Cost 5y 0.78%
Annual Growth 5y -32.80%
Payout Consistency 76.3%

CGNX Growth Ratios

Growth Correlation 3m -78.4%
Growth Correlation 12m -70.5%
Growth Correlation 5y -77.7%
CAGR 5y -5.51%
CAGR/Max DD 5y -0.08
Sharpe Ratio 12m -0.04
Alpha -38.30
Beta 1.424
Volatility 33.46%
Current Volume 4407.6k
Average Volume 20d 1739.7k
What is the price of CGNX stocks?
As of April 01, 2025, the stock is trading at USD 29.83 with a total of 4,407,576 shares traded.
Over the past week, the price has changed by -5.51%, over one month by -9.05%, over three months by -16.61% and over the past year by -27.98%.
Is Cognex a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cognex is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -7.43 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CGNX as of April 2025 is 24.56. This means that CGNX is currently overvalued and has a potential downside of -17.67%.
Is CGNX a buy, sell or hold?
Cognex has received a consensus analysts rating of 3.86. Therefor, it is recommend to buy CGNX.
  • Strong Buy: 9
  • Buy: 2
  • Hold: 10
  • Sell: 1
  • Strong Sell: 0
What are the forecast for CGNX stock price target?
According to ValueRays Forecast Model, CGNX Cognex will be worth about 27.8 in April 2026. The stock is currently trading at 29.83. This means that the stock has a potential downside of -6.67%.
Issuer Forecast Upside
Wallstreet Target Price 42.6 42.7%
Analysts Target Price 47.2 58.3%
ValueRay Target Price 27.8 -6.7%